Pharmaceutical giants have challenged Trump's new Medicare drug pricing program, alleging federal officials exceeded their authority and violated the Constitution.
Pharmaceutical giants have challenged Trump's new Medicare drug pricing program, alleging federal officials exceeded their authority and violated the Constitution.